RXi Pharmaceuticals Corporation announced the appointment of Dr. Gerrit Dispersyn as its President and Chief Operating Officer. As COO, he will oversee all day-to-day activities of the company and is in line to become the next CEO of the company. Dr. Dispersyn has been the company's Chief Development Officer since April 2017. Effective November 14, 2018, Dr. Cauwenbergh remains as CEO and a member of the Board of Directors of the company and will focus on financial, intellectual property and strategic matters.